WhitTier Trust Company’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.87K Hold
61
﹤0.01% 1175
2026
Q1
$2.98K Buy
61
+40
+190% +$1.87K ﹤0.01% 1221
2025
Q4
$749 Hold
21
﹤0.01% 1230
2025
Q3
$598 Buy
+21
New +$586 ﹤0.01% 1232
2025
Q2
Sell
-5
Closed -$141 1468
2025
Q1
$141 Buy
+5
New +$177 ﹤0.01% 1402
2024
Q4
Sell
-5
Closed -$333 1387
2024
Q3
$333 Hold
5
﹤0.01% 1300
2024
Q2
$593 Hold
5
﹤0.01% 1226
2024
Q1
$532 Buy
5
+2
+67% +$202 ﹤0.01% 1183
2023
Q4
$298 Buy
+3
New +$252 ﹤0.01% 1184
2023
Q2
Sell
-3
Closed -$460 1183
2023
Q1
$460 Sell
3
-54
-95% -$8.91K ﹤0.01% 1135
2022
Q4
$10.2K Buy
+57
New +$9.32K ﹤0.01% 942

Other funds holding MRNA

WhitTier Trust Company's MRNA Position: Q2 2026 in Review

WhitTier Trust Company held its Moderna (MRNA) position steady in Q2 2026 at 61 shares worth $4.87K. The position accounts for ﹤0.01% of the portfolio, ranked #1175.

WhitTier Trust Company first reported a position in MRNA in Q4 2022 and has held it in 11 quarters since. The position peaked at $10.2K in Q4 2022. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • WhitTier Trust Company held 61 shares of Moderna worth $4.87K as of Q2 2026.
  • WhitTier Trust Company left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #1175 holding.
  • WhitTier Trust Company first reported a position in Moderna in Q4 2022 and has held it in 11 quarters since.
  • WhitTier Trust Company's Moderna position peaked at $10.2K in Q4 2022.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.